SERA vs. AUNA, FTRE, TALK, SBC, CELC, EHAB, INNV, PSNL, VMD, and LFMD
Should you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include Auna (AUNA), Fortrea (FTRE), Talkspace (TALK), SBC Medical Group (SBC), Celcuity (CELC), Enhabit (EHAB), InnovAge (INNV), Personalis (PSNL), Viemed Healthcare (VMD), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.
Sera Prognostics vs.
Sera Prognostics (NASDAQ:SERA) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment.
Sera Prognostics has higher earnings, but lower revenue than Auna. Sera Prognostics is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.
Sera Prognostics received 3 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 38.46% of users gave Sera Prognostics an outperform vote.
Auna's return on equity of 0.00% beat Sera Prognostics' return on equity.
In the previous week, Sera Prognostics and Sera Prognostics both had 2 articles in the media. Sera Prognostics' average media sentiment score of 1.67 beat Auna's score of -0.10 indicating that Sera Prognostics is being referred to more favorably in the media.
Auna has a consensus target price of $13.50, indicating a potential upside of 94.10%. Given Auna's higher possible upside, analysts plainly believe Auna is more favorable than Sera Prognostics.
54.6% of Sera Prognostics shares are held by institutional investors. 15.8% of Sera Prognostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Auna beats Sera Prognostics on 7 of the 13 factors compared between the two stocks.
Get Sera Prognostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sera Prognostics Competitors List
Related Companies and Tools
This page (NASDAQ:SERA) was last updated on 4/24/2025 by MarketBeat.com Staff
Buy SERA Stock Free SERA Stock Alerts